Navigation Links
BioConference Live Call for Abstracts
Date:6/4/2009

First of its Kind Virtual Event Scheduled for November 17-19, 2009. Deadline for Abstract Submission June 26, 2009

Boston, MA (PRWEB) June 4, 2009 -- PlatformQ and LabRoots announced that an open call for abstracts for BioConference Live has been extended to June 26, 2009. BioConference Live is a first of its kind virtual event for scientists, engineers, and other technical professionals. BioConference Live will take place from Tuesday through Thursday, November 17-19, 2009, and will feature live video keynote presentations from senior scientists in the life sciences. Attendees can have their questions answered by presenters in a live online conference.

BioConference Live seeks additional case studies in biotechnology, neuroscience, genetics, cell biology, cancer research, analytical chemistry and lab automation. A virtual exhibit hall will feature poster sessions that present and discuss recent work.

The BioConference Live virtual event makes it easier and more cost-effective than ever before for scientists and academicians to come together online, virtually transcending the barriers of time and distance. Researchers can extend their reach and gather feedback on their work from the convenience of any computer.

"Our mission is to enable scientists to connect with each other and foster meaningful collaborations across geographic boundaries and fields of expertise," said Greg Cruickshank, CEO, President and Founder of LabRoots. "PlatformQ is the premier provider of virtual events, so it is natural that we would work together to create a live online event for our community of scientists."

"We are excited to leverage our digital media expertise to produce BioConference Live in collaboration with LabRoots," said Robert Rosenbloom, CEO of PlatformQ. "The LabRoots community of scientists and academicians is at ease interacting online. Bioconference Live will extend the experience of the social network with a live digital event, featuring streaming video presentations, live chat, and a virtual exhibit floor."

Topics:

 
  • Cell Biology
  • Genetics
  • Cancer Research
  • Laboratory Automation
  • Neuroscience
  • Molecular Biology
  • Biotechnology
  • Drug Discovery
  • Immunology/Microbiology
  • Analytical Chemistry

Confirmed speakers include:
 
  • Christopher Druzgalski, Ph.D., Professor of Biomedical/Clinical and Electrical Engineering, California State Long Beach, President of ACSUP (Association of California State University Professors, Chair of Pan American Health Care Exchanges (PAHCE)
  • Robert Malone, M.D., M.S. , Associate Professor of Biotechnology at Kennesaw University, Editor in Chief at Journal of Immune Based Therapies and Vaccines, Medical Director at Accelovance
  • Arthur M. "Buzz" Brown, M.D., Ph.D., Adjunct Professor of Physiology and Biophysics, School of Medicine, Case Western Reserve University, founder and CEO of ChanTest Corporation
  • Thomas R. Insel, M.D., Director of the National Institute of Mental Health. founding director of the Center for Behavioral Neuroscience, a science and technology center, funded by the National Science Foundation (NSF)
  • Harold McNair, Ph. D., Professor Emeritus of analytical chemistry at Virginia Tech, one of the founders of modern chromatography
  • Lin Wu, M.D., Senior Scientist, Pharmacological Sciences, CV Therapeutics Inc.
  • Stephen N. Oesterle, M.D. Sr. VP, Medicine & Technology, Medtronic, Inc.

Click here to Submit Abstract Now!
*If you have any difficulties with the electronic submission form, please email your abstract to Abstracts@BioConferenceLive.com. To learn more about abstract submission and track presentation, contact:
Abstracts (at) BioConferenceLive (dot) com, or call (714) 269-2986.

To sponsor BioConference Live contact: Sponsors (at) BioConferenceLive (dot) com or call (714) 926-6384.

About PlatformQ
PlatformQ is a digital media company that produces digital events in the education, energy and healthcare markets. PlatformQ connects people, organizations, and associations worldwide, to let them meet, interact with and learn from leading experts and thought leaders at online events. Virtual events produced by PlatformQ offer great access to content, real-time networking, interactivity, global reach, and efficient use of time and resources for attendees. PlatformQ events provide marketers with a measurable, targeted, and contextual environment for promoting products and services.

About LabRoots
LabRoots is a professional networking utility designed for the scientific community. It is based on individual scientific expertise, discipline, and aptitude. LabRoots is relevant for all laboratory scientists including those in Life Science, Clinical Science, Health Science, Medical Science, Environmental Science, Earth Science, Space Science, Chemistry, Physics, Mathematics, Engineering and Computer Science. Find more information at http://www.LabRoots.com

BioConference Live and PlatformQ are trademarks of PlatformQ, LLC. All other trademarks or service marks are property of their respective owners.

Press Contact: Martha Collins, press (at) BioConferenceLive (dot) com, 617-938-6008

# # #

Read the full story at http://www.prweb.com/releases/2009/06/prweb2490174.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. PlatformQ and LabRoots Announce BioConference Live, Online Conference for the Life Science Research and Laboratory Sciences Community
2. NewCardio Medical and Technology Team Presents Two Abstracts at Heart Rhythm Society Conference
3. 25 Clinical Abstracts at National Conference Spotlight Clinical Utility of Somanetics INVOS System in Neonates
4. Obesity Society Announces 2009 Call for Abstracts
5. Agile Therapeutics Abstracts on Lead Product, AG200-15 Accepted by ACOG
6. Twenty New Abstracts on Oral Xeloda(R) (capecitabine) Featured at the 31st San Antonio Breast Cancer Symposium
7. Memory Pharmaceuticals Announces Six Abstracts Accepted for Presentation at Society for Neuroscience Meeting
8. DaVita Abstracts Accepted into American Society of Nephrology Meeting
9. Innovative Atrial Fibrillation (AF) Catheter Ablation System From Ablation Frontiers is Subject of Two Abstracts at Heart Rhythm Congress UK
10. CHEST 2008: Featured abstracts
11. Assessing the quality of phase I clinical trial abstracts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Worth, TX (PRWEB) , ... October 13, 2017 ... ... financial planning agency serving communities in the greater Dallas, Miami, and Raleigh regions, ... young boy fighting to overcome a rare and deadly chromosome abnormality. , After ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... As health ... medicine known as “patient engagement.” The patient is doing more than filling out a ... , “There is an increasing emphasis in health care and research on the ...
(Date:10/13/2017)... ... 2017 , ... The American Board of Family Medicine's (ABFM) Board of Directors ... Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve in ... retirement at the end of 2018. Upon assuming the role of President and CEO ...
(Date:10/13/2017)... ... 2017 , ... PurhealthRX , a leading Health and Nutrition Company, is ... to full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing ... easily incorporated into liquid products, while reducing costs to end users. , The team ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the Law ... organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our ... a forum to network with elder law attorneys nationwide,” said Somekh. , ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
Breaking Medicine Technology: